Venue
Hung Hom Room 1, Level 1, Kerry Hotel, Hong Kong,
| Time | Programme | Speaker |
|---|---|---|
| 0900 - 0910 | Opening remarks | Jeremy YC TEOH |
| Session I | Kidney Cancer & UTUC | |
| Moderators: Riccardo CAMPI, Chi Wai FAN, Philip WK KWONG, Francis CH WONG | ||
| 0910 - 1030 | Kidney-sparing treatment for UTUC: Current landscape and future directions | Morgan ROUPRET |
| Robotic partial nephrectomy for complex renal tumours | Mallikarjuna CHIRUVELLA | |
| Local and metastasis-directed therapy for metastatic renal cell carcinoma | David KW LEUNG | |
| Managing immuno-oncology toxicities: A practical guide | Daisy CM LAM | |
| 1030 - 1100 | Tea break | |
| Session II | Bladder Cancer | |
| Moderators: Thomas YC LAM, Bryan CW LI, Jeremy YC TEOH, Ivan CF TSANG | ||
| 1100 - 1220 | Novel therapies for non-muscle-invasive bladder cancer | Paolo GONTERO |
| Optimising cystectomy outcomes in muscle-invasive bladder cancer | Takafumi YANAGISAWA | |
| Trimodality therapy for muscle-invasive bladder cancer in the modern era | Kelvin CK YAN | |
| Paradigm shift in the management of advanced urothelial carcinoma | Satoshi KATAYAMA |
|
| Lunch Symposium | ||
| Moderators: Brian SH HO, Chi Man NG | ||
| 1220 - 1250 | En bloc resection of bladder tumour: Where are we now? | Jeremy YC TEOH |
| 1250 - 1320 | Lunch | |
| Session III | Prostate Cancer | |
| Moderators: Rossella NICOLETTI, Peter KF CHIU, Kitty KS LAW, Po Chor TAM | ||
| 1320 - 1500 | Unraveling the role of AR agents in mHSPC patients: Clinical value beyond PSA | Edmund CHIONG |
| Evolving the hormone sensitive prostate cancer landscape | Henry WOO | |
| Emerging trends in mHSPC treatment: What's on the horizon? | Fred SAAD | |
| Prostate cancer management with PARPi | Takahiro KIMURA | |
| ESMO update in prostate cancer | Fred SAAD | |
| Session IV | Hot Topics in Urological Cancers | |
| Moderators: Peggy SK CHU, Raymond WM KAN, Samuel CH YEE, Victor HW YEUNG | ||
| 1500 - 1620 | Comprehensive care alongside the use of androgen deprivation therapy | Rossella NICOLETTI |
| Role of CEUS, MRI and PET in RCC diagnosis | Victor KH LEE | |
| Retroperitoneal tumours: What does a urologist need to know? | Mandy HM TAM | |
| Shall we make sentinel lymph node biopsy a routine in penile cancer management? | Samson YS CHAN | |
| 1620 - 1630 | Closing remarks | Jeremy YC TEOH |
